• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) ONYX; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) ONYX; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Device Problem Entrapment of Device (1212)
Patient Problems Infarction, Cerebral (1771); Neurological Deficit/Dysfunction (1982); Perforation (2001); Foreign Body In Patient (2687)
Event Date 12/26/2008
Event Type  Injury  
Manufacturer Narrative
Hauck, e., welch, b., white, j., purdy, p., pride, l., and samson, d.(2009).Preoperative embolization of cerebral arteriovenous malformations with onyx.American journal of neuroradiology, 30(3), 492-495.Doi:10.3174/ajnr.A1376.The onyx will not be returned for evaluation as it remains in the patients.The onyx model and lot numbers were not provided.The article provided limited information on these events.A cause for the reported events could not be conclusively determined.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic literature review found reports of patient complications during or after onyx embolization.The purpose of this article was to investigate the risks of preoperative cerebral arteriovenous malformations (cavms) with onyx.The authors identified 41 patients who underwent preoperative cavm onyx embolization in 82 procedures; median age was 41 years, 15 were male and 26 were female.Onyx was either used as the sole embolic agent or in conjunction with other materials.In these patients, the intent was to reduce flow in the cavm in order to reduce the risk and increase success of subsequent treatment (usually surgery).The article states that permanent neurological deficit (>6months) occurred in five patients: one patient experienced a small biophthalamic infarct with mild cognitive deficit and difficulties with calculations after the initial embolization of a pineal region cavm - two patients with cerebellar avms experienced mild ataxia and dysmetria after initial embolization.Ct scan revealed a new cerebellar hypoattenuation.One patient experienced new persistent hemiparesis after a fourth embolization of a large frontal cavm.During embolization, the patient experienced a perforation with a small intraparenchymal hemorrhage in the posterior frontal lobe.One patient ((b)(6), female) underwent partial onyx embolization of a large, left-sided frontotempoparietal cavm with the intent to treat an intranidal feeding aneurysm.The feeding aneurysm was completely occluded; the patient experienced new aphasia and hemiparesis.Asymptomatic technical complications occurred in 16 patients: nine patients experienced asymptomatic small vessel perforation (contrast extravasation or hemorrhage on post-procedure ct) - three patients experienced new lacunar infarct without neurological deficit (documented on post-procedure mri or ct) - microcatheter (unknown manufacturer) was retained in four procedures, which was then removed during surgery without neurological consequences.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key6652811
MDR Text Key77915418
Report Number2029214-2017-00798
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 05/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/22/2017
Initial Date FDA Received06/20/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-